Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.60
-0.46 (-3.27%)
At close: Aug 1, 2025, 4:00 PM
13.60
0.00 (0.01%)
After-hours: Aug 1, 2025, 7:58 PM EDT
Chimerix Market Cap
Carlsmed has a market cap or net worth of $360.62 million as of August 1, 2025.
Market Cap
360.62M
Enterprise Value
334.27M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.60
Market Cap Chart
Since the IPO on July 23, 2025, Carlsmed's market cap has decreased from $397.74M to $360.62M, a decrease of -9.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 360.62M | -3.27% |
| Jul 31, 2025 | 372.82M | -3.76% |
| Jul 30, 2025 | 387.40M | 0.76% |
| Jul 29, 2025 | 384.49M | - |
| Jul 28, 2025 | 384.49M | - |
| Jul 25, 2025 | 384.49M | 0.35% |
| Jul 24, 2025 | 383.16M | -3.67% |
| Jul 23, 2025 | 397.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.59B |
| Johnson & Johnson | 400.87B |
| AbbVie | 344.13B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 222.12B |
| UnitedHealth Group | 218.34B |
| Novo Nordisk | 213.92B |